Mercury is usually added to skin-lightening products due to its whitening effect. The Food and Drug Administration (FDA) limits the amount of mercury in cosmetics to trace amounts under 1 ppm. Nevertheless, many cosmetics contain mercury above 1000 ppm to increase the whitening effect. In a group of special patients in the study, pain, renal damage, and neuropsychiatric symptoms were the cardinal symptoms observed.

The present study included 16 female patients diagnosed with chronic mercury intoxication at the First Affiliated Hospital of Zhengzhou University from 2009 to 2017. The age of these patients ranged from 19 to 50 years. All the 16 patients had a flexuose treatment experience, slow onset, and a hidden history that contributed the delayed diagnosis. There was no history of exposure to mercury in their work, but all of them had a history of using skin-lightening products, which had immediate and dramatic whitening effects. The chief complaint was miserable pain, and limb, head, abdomen, or lumbosacral pain was poorly responsible for nonsteroidal anti-inflammatory drugs, anti-epileptic drugs, and serotonin-norepinephrine reuptake inhibitors. According to the World Health Organization visual analog scale ranking, 0 referred to no pain and 10 referred to baryodynia. The pain of these 16 patients was rated between 4 and 7. Renal damage was another characteristic, in which six of all the patients presented with proteinuria. In addition, all patients had varying degrees of irritability, insomnia, dreams, depression, anxiety, and memory loss. Furthermore, five patients presented with eyelid, tongue, or limb tremors, while three patients presented with gingivitis.

The 24-h urine mercury content of these patients was within 0.037--0.170 mg/L (normal value, \<0.010 mg/L). In one skin-lightening product sample, the mercury concentration was found to be 19,742 ± 379 ppm, which is 19,000 times higher than the FDA limit. The electromyography examination was normal in 11 patients, while it was abnormal in five patients; and slow sensory nerve conduction velocity and reduced amplitude were mainly observed. Moreover, the brain magnetic resonance imaging and lumbar puncture of seven patients with headache were normal. Hamilton Depression Scale-17 (HAMD-17, normal value \<7 points) scores were within 9--20 points \[[Supplementary Table 1](#T1){ref-type="table"}\]. All patients received intravenous sodium dimercaptopropane sulfonate at 0.125 g/d and other symptomatic treatments.

###### 

Signs, symptoms, and other findings of these patients

  Case   Age (years)   Latency from using the product to symptom onset (weeks)   Avenue of purchase   Main symptoms                                         Accompanied symptoms and signs                                                   VAS ranking   Urine mercury   EMG                                                                                                                HAMD score
  ------ ------------- --------------------------------------------------------- -------------------- ----------------------------------------------------- -------------------------------------------------------------------------------- ------------- --------------- ------------------------------------------------------------------------------------------------------------------ ------------
  1      36            4                                                         Online               Headache, back pain                                   Hypomnesia, insomnia, irritability, often cries                                  6             0.160 mg/L      Conduction velocity of the bilateral endings of the median sensory nerve was slower, and the amplitude decreased   25
  2      33            6                                                         Online               Pain in the four limbs, abdominal pain                Eyelid tremor, finger tremor, irritability, distraction, renal damage            6             0.140 mg/L      Normal                                                                                                             18
  3      30            9                                                         Online               Pain in the four limbs                                Both hand tremor, distracted, insomnia, renal damage                             7             0.170 mg/L      The amplitude of the bilateral common peroneal nerve decreased                                                     16
  4      37            13                                                        Beauty shop          Headache and pain in the four limbs                   Insomnia, gingivitis                                                             5             0.110 mg/L      Normal                                                                                                             13
  5      40            5                                                         Beauty shop          Foot pain                                             Difficulty in falling asleep, distracted                                         5             0.090 mg/L      Normal                                                                                                             10
  6      19            7                                                         Online               Lumbosacral pain, abdominal pain                      Eyelid tremor, lingual tremor, hand tremor, insomnia, gingivitis, renal damage   6             0.150 mg/L      Conduction velocity of the bilateral tibial and peroneal sensory nerve was slower, and the amplitude decreased     26
  7      39            10                                                        Online               Pain in the four limbs                                Difficulty in falling asleep                                                     4             0.037 mg/L      Normal                                                                                                             17
  8      35            6                                                         Store                Headache and pain in the four limbs                   Renal damage, insomnia                                                           6             0.120 mg/L      Normal                                                                                                             10
  9      29            8                                                         Store                Pain in the four limbs                                Insomnia, distracted                                                             4             0.080 mg/L      Normal                                                                                                             12
  10     36            5                                                         Store                Pain in both lower extremities, lumbosacral pain      Insomnia, distracted, hypomnesia, irritability                                   6             0.130 mg/L      Conduction velocity of the bilateral tibial and sensory nerve was slower, and the amplitude decreased              22
  11     32            7                                                         Online               Pain in both lower extremities and lumbosacral pain   Renal damage                                                                     4             0.106 mg/L      Normal                                                                                                             19
  12     27            5                                                         WeChat shop          Pain in both lower extremities and abdominal pain     Lingual tremor, hand tremor, insomnia, gingivitis, irritability                  6             0.120 mg/L      Normal                                                                                                             21
  13     42            8                                                         Beauty Shop          Headache and pain in the four limbs                   Limb tremor, hypomnesia, insomnia, irritability, renal damage                    6             0.110 mg/L      Normal                                                                                                             24
  14     41            12                                                        Online               Pain in the four limbs                                Difficulty in falling asleep, irritability                                       4             0.076 mg/L      Normal                                                                                                             16
  15     50            11                                                        Store                Headache, pain in the four limbs                      Hypomnesia, insomnia, irritability                                               5             0.130 mg/L      Normal                                                                                                             15
  16     33            12                                                        Online               Pain in both lower extremities and abdominal pain     Irritability, insomnia, renal damage, hypomnesia                                 6             0.110 mg/L      Conduction velocity of the bilateral tibial and sensory nerve was slower, and the amplitude decreased              24

VAS: Visual analog scale; EMG: Electromyography; HAMD: Hamilton Depression Scale.

Mercury ions replace tyrosinase enzyme anions, which inhibit the formation of melanin and produce the whitening and anti-freckle effects.\[[@ref1]\] Some products are added with the mercury content, which exceeds bid badly in thousands or even millions of times, in order to make the lightening effect remarkable. The long-term usage of these unqualified products would induce chronic mercury poisoning.

The common symptoms of chronic mercury poisoning are irritability, tremor, and gingivitis, while the onset of pain is rare. Furthermore, it has been reported that it causes memory loss, dizziness, insomnia, dreams, edema, proteinuria, abdominal pain, nausea, hyperthyroidism, and abortion. Studies on mercury poisoning, which leads to peripheral nerve damage, are rare. Patients in the present study prominently complained of pain, but rarely referred to limb weakness. Distal extremity hypoalgesia was not observed, and all patients had no severe central nervous system symptoms, such as lags in response, seizures, confusion, difficulty in swallowing, glossolalia, deafness, narrow field of vision, strabismus, or photophobia, which were similar with Minamata disease.\[[@ref2]\]

Mercury damages the nerves in several ways: it interferes with membrane and receptor functions, and neurotransmitter transport and metabolism; it interrupts cytoskeletal proteins, and interferes with axoplasmic flow and signal transduction; it interferes with cell respiration, energy metabolism and others.\[[@ref3]\] Among the 16 patients, six patients presented with proteinuria, but without edema. After 3--5 courses of chelation treatment, urine mercury returned to normal levels. Then, after approximately 4--8 weeks, pain was alleviated, urine protein was negative, and HAMD scale scores returned to normal.

Unqualified products that contain toxic substances such as mercury are not rare. These substances usually damage the nervous and renal systems. Hence, history taking is all important, and mercury chelation treatment should be given after diagnosis as soon as possible. Furthermore, the public should be warned about this danger.
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